+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Idiopathic Pulmonary Fibrosis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • PDF Icon

    Report

  • 95 Pages
  • February 2024
  • Region: Global
  • Prof Research
  • ID: 5911101
Description Jump to:

Quick Summary:

In an ever-evolving healthcare landscape, the Idiopathic Pulmonary Fibrosis (IPF) Drug market stands as a beacon of opportunity for astute senior executives. At the crux of strategic decision-making is sound market intelligence, which is why our comprehensive report on the global IPF Drug market is an indispensable asset for leaders seeking a competitive edge.

Our meticulously crafted report delves into the nuanced dynamics of regional IPF Drug supply and demand patterns, while spotlighting pivotal industry players in key geographies such as North America, Europe, and Asia-Pacific. It encapsulates an array of market data, including in-depth profiles of leading companies, their strategic orientations, and market positioning, set against the backdrop of robust historical data and future projections.

Armed with this report, executives are poised to make informed decisions, leveraging insights on prominent drug types such as nintedanib and pirfenidone, and evaluating the competitive landscape through comprehensive SWOT analyses. In a market pulsing with potential, this report is your guide to navigating the complex terrain of IPF Drug market opportunities with confidence.

This report describes the global market size of Idiopathic Pulmonary Fibrosis Drug from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Idiopathic Pulmonary Fibrosis Drug as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Types Segment

  • nintedanib
  • pirfenidone
  • Others

Companies Covered

  • AstraZeneca PLC
  • Boehringer Ingelheim
  • Bristol Myers Squibb Co.
  • Novartis AG
  • Avalyn Pharma Inc.
  • Bellerophon Therapeutics Inc.
  • Endeavor Biomedicines Inc.
  • Horizon Therapeutics Public Limited Company
  • Pliant Therapeutics Inc.
  • Suzhou Zelgen Biopharmaceuticals Co. Ltd.
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Idiopathic Pulmonary Fibrosis Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Idiopathic Pulmonary Fibrosis Drug Market in North America (2019-2029)
8.1 Idiopathic Pulmonary Fibrosis Drug Market Size
8.2 Idiopathic Pulmonary Fibrosis Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Idiopathic Pulmonary Fibrosis Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Idiopathic Pulmonary Fibrosis Drug Market in South America (2019-2029)
9.1 Idiopathic Pulmonary Fibrosis Drug Market Size
9.2 Idiopathic Pulmonary Fibrosis Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Idiopathic Pulmonary Fibrosis Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Idiopathic Pulmonary Fibrosis Drug Market in Asia & Pacific (2019-2029)
10.1 Idiopathic Pulmonary Fibrosis Drug Market Size
10.2 Idiopathic Pulmonary Fibrosis Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Idiopathic Pulmonary Fibrosis Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Idiopathic Pulmonary Fibrosis Drug Market in Europe (2019-2029)
11.1 Idiopathic Pulmonary Fibrosis Drug Market Size
11.2 Idiopathic Pulmonary Fibrosis Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Idiopathic Pulmonary Fibrosis Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Idiopathic Pulmonary Fibrosis Drug Market in MEA (2019-2029)
12.1 Idiopathic Pulmonary Fibrosis Drug Market Size
12.2 Idiopathic Pulmonary Fibrosis Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Idiopathic Pulmonary Fibrosis Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Idiopathic Pulmonary Fibrosis Drug Market (2019-2024)
13.1 Idiopathic Pulmonary Fibrosis Drug Market Size
13.2 Idiopathic Pulmonary Fibrosis Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Idiopathic Pulmonary Fibrosis Drug Market Size by Type
Chapter 14 Global Idiopathic Pulmonary Fibrosis Drug Market Forecast (2024-2029)
14.1 Idiopathic Pulmonary Fibrosis Drug Market Size Forecast
14.2 Idiopathic Pulmonary Fibrosis Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Idiopathic Pulmonary Fibrosis Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 AstraZeneca PLC
15.1.1 Company Profile
15.1.2 Main Business and Idiopathic Pulmonary Fibrosis Drug Information
15.1.3 SWOT Analysis of AstraZeneca PLC
215.1.4 AstraZeneca PLC Idiopathic Pulmonary Fibrosis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.2 Boehringer Ingelheim
15.2.1 Company Profile
15.2.2 Main Business and Idiopathic Pulmonary Fibrosis Drug Information
15.2.3 SWOT Analysis of Boehringer Ingelheim
215.2.4 Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.3 Bristol Myers Squibb Co.
15.3.1 Company Profile
15.3.2 Main Business and Idiopathic Pulmonary Fibrosis Drug Information
15.3.3 SWOT Analysis of Bristol Myers Squibb Co.
215.3.4 Bristol Myers Squibb Co. Idiopathic Pulmonary Fibrosis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.4 Novartis AG
15.4.1 Company Profile
15.4.2 Main Business and Idiopathic Pulmonary Fibrosis Drug Information
15.4.3 SWOT Analysis of Novartis AG
215.4.4 Novartis AG Idiopathic Pulmonary Fibrosis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.5 Avalyn Pharma Inc.
15.5.1 Company Profile
15.5.2 Main Business and Idiopathic Pulmonary Fibrosis Drug Information
15.5.3 SWOT Analysis of Avalyn Pharma Inc.
215.5.4 Avalyn Pharma Inc. Idiopathic Pulmonary Fibrosis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.6 Bellerophon Therapeutics Inc.
15.6.1 Company Profile
15.6.2 Main Business and Idiopathic Pulmonary Fibrosis Drug Information
15.6.3 SWOT Analysis of Bellerophon Therapeutics Inc.
215.6.4 Bellerophon Therapeutics Inc. Idiopathic Pulmonary Fibrosis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.7 Endeavor Biomedicines Inc.
15.7.1 Company Profile
15.7.2 Main Business and Idiopathic Pulmonary Fibrosis Drug Information
15.7.3 SWOT Analysis of Endeavor Biomedicines Inc.
215.7.4 Endeavor Biomedicines Inc. Idiopathic Pulmonary Fibrosis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.8 Horizon Therapeutics Public Limited Company
15.8.1 Company Profile
15.8.2 Main Business and Idiopathic Pulmonary Fibrosis Drug Information
15.8.3 SWOT Analysis of Horizon Therapeutics Public Limited Company
215.8.4 Horizon Therapeutics Public Limited Company Idiopathic Pulmonary Fibrosis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.9 Pliant Therapeutics Inc.
15.9.1 Company Profile
15.9.2 Main Business and Idiopathic Pulmonary Fibrosis Drug Information
15.9.3 SWOT Analysis of Pliant Therapeutics Inc.
215.9.4 Pliant Therapeutics Inc. Idiopathic Pulmonary Fibrosis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.10 Suzhou Zelgen Biopharmaceuticals Co. Ltd.
15.10.1 Company Profile
15.10.2 Main Business and Idiopathic Pulmonary Fibrosis Drug Information
15.10.3 SWOT Analysis of Suzhou Zelgen Biopharmaceuticals Co. Ltd.
215.10.4 Suzhou Zelgen Biopharmaceuticals Co. Ltd. Idiopathic Pulmonary Fibrosis Drug Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Idiopathic Pulmonary Fibrosis Drug Report
Table Data Sources of Idiopathic Pulmonary Fibrosis Drug Report
Table Major Assumptions of Idiopathic Pulmonary Fibrosis Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Idiopathic Pulmonary Fibrosis Drug Picture
Table Idiopathic Pulmonary Fibrosis Drug Classification
Table Idiopathic Pulmonary Fibrosis Drug Applications
Table Drivers of Idiopathic Pulmonary Fibrosis Drug Market
Table Restraints of Idiopathic Pulmonary Fibrosis Drug Market
Table Opportunities of Idiopathic Pulmonary Fibrosis Drug Market
Table Threats of Idiopathic Pulmonary Fibrosis Drug Market
Table COVID-19 Impact For Idiopathic Pulmonary Fibrosis Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Idiopathic Pulmonary Fibrosis Drug
Table Cost Structure Analysis of Idiopathic Pulmonary Fibrosis Drug
Table Key End Users
Table Latest News of Idiopathic Pulmonary Fibrosis Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Idiopathic Pulmonary Fibrosis Drug Market
Table Policy of Idiopathic Pulmonary Fibrosis Drug Market
Table 2019-2029 North America Idiopathic Pulmonary Fibrosis Drug Market Size
Figure 2019-2029 North America Idiopathic Pulmonary Fibrosis Drug Market Size and CAGR
Table 2019-2029 North America Idiopathic Pulmonary Fibrosis Drug Market Size by Application
Table 2019-2024 North America Idiopathic Pulmonary Fibrosis Drug Key Players Revenue
Table 2019-2024 North America Idiopathic Pulmonary Fibrosis Drug Key Players Market Share
Table 2019-2029 North America Idiopathic Pulmonary Fibrosis Drug Market Size by Type
Table 2019-2029 United States Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 Canada Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 Mexico Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 South America Idiopathic Pulmonary Fibrosis Drug Market Size
Figure 2019-2029 South America Idiopathic Pulmonary Fibrosis Drug Market Size and CAGR
Table 2019-2029 South America Idiopathic Pulmonary Fibrosis Drug Market Size by Application
Table 2019-2024 South America Idiopathic Pulmonary Fibrosis Drug Key Players Revenue
Table 2019-2024 South America Idiopathic Pulmonary Fibrosis Drug Key Players Market Share
Table 2019-2029 South America Idiopathic Pulmonary Fibrosis Drug Market Size by Type
Table 2019-2029 Brazil Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 Argentina Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 Chile Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 Peru Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 Asia & Pacific Idiopathic Pulmonary Fibrosis Drug Market Size
Figure 2019-2029 Asia & Pacific Idiopathic Pulmonary Fibrosis Drug Market Size and CAGR
Table 2019-2029 Asia & Pacific Idiopathic Pulmonary Fibrosis Drug Market Size by Application
Table 2019-2024 Asia & Pacific Idiopathic Pulmonary Fibrosis Drug Key Players Revenue
Table 2019-2024 Asia & Pacific Idiopathic Pulmonary Fibrosis Drug Key Players Market Share
Table 2019-2029 Asia & Pacific Idiopathic Pulmonary Fibrosis Drug Market Size by Type
Table 2019-2029 China Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 India Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 Japan Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 South Korea Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 Southeast Asia Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 Australia Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 Europe Idiopathic Pulmonary Fibrosis Drug Market Size
Figure 2019-2029 Europe Idiopathic Pulmonary Fibrosis Drug Market Size and CAGR
Table 2019-2029 Europe Idiopathic Pulmonary Fibrosis Drug Market Size by Application
Table 2019-2024 Europe Idiopathic Pulmonary Fibrosis Drug Key Players Revenue
Table 2019-2024 Europe Idiopathic Pulmonary Fibrosis Drug Key Players Market Share
Table 2019-2029 Europe Idiopathic Pulmonary Fibrosis Drug Market Size by Type
Table 2019-2029 Germany Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 France Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 United Kingdom Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 Italy Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 Spain Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 Belgium Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 Netherlands Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 Austria Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 Poland Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 Russia Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 MEA Idiopathic Pulmonary Fibrosis Drug Market Size
Figure 2019-2029 MEA Idiopathic Pulmonary Fibrosis Drug Market Size and CAGR
Table 2019-2029 MEA Idiopathic Pulmonary Fibrosis Drug Market Size by Application
Table 2019-2024 MEA Idiopathic Pulmonary Fibrosis Drug Key Players Revenue
Table 2019-2024 MEA Idiopathic Pulmonary Fibrosis Drug Key Players Market Share
Table 2019-2029 MEA Idiopathic Pulmonary Fibrosis Drug Market Size by Type
Table 2019-2029 Egypt Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 Israel Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 South Africa Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 Gulf Cooperation Council Countries Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2029 Turkey Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2019-2024 Global Idiopathic Pulmonary Fibrosis Drug Market Size by Region
Table 2019-2024 Global Idiopathic Pulmonary Fibrosis Drug Market Size Share by Region
Table 2019-2024 Global Idiopathic Pulmonary Fibrosis Drug Market Size by Application
Table 2019-2024 Global Idiopathic Pulmonary Fibrosis Drug Market Share by Application
Table 2019-2024 Global Idiopathic Pulmonary Fibrosis Drug Key Vendors Revenue
Figure 2019-2024 Global Idiopathic Pulmonary Fibrosis Drug Market Size and Growth Rate
Table 2019-2024 Global Idiopathic Pulmonary Fibrosis Drug Key Vendors Market Share
Table 2019-2024 Global Idiopathic Pulmonary Fibrosis Drug Market Size by Type
Table 2019-2024 Global Idiopathic Pulmonary Fibrosis Drug Market Share by Type
Table 2024-2029 Global Idiopathic Pulmonary Fibrosis Drug Market Size by Region
Table 2024-2029 Global Idiopathic Pulmonary Fibrosis Drug Market Size Share by Region
Table 2024-2029 Global Idiopathic Pulmonary Fibrosis Drug Market Size by Application
Table 2024-2029 Global Idiopathic Pulmonary Fibrosis Drug Market Share by Application
Table 2024-2029 Global Idiopathic Pulmonary Fibrosis Drug Key Vendors Revenue
Figure 2024-2029 Global Idiopathic Pulmonary Fibrosis Drug Market Size and Growth Rate
Table 2024-2029 Global Idiopathic Pulmonary Fibrosis Drug Key Vendors Market Share
Table 2024-2029 Global Idiopathic Pulmonary Fibrosis Drug Market Size by Type
Table 2024-2029 Idiopathic Pulmonary Fibrosis Drug Global Market Share by Type

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AstraZeneca PLC
  • Boehringer Ingelheim
  • Bristol Myers Squibb Co.
  • Novartis AG
  • Avalyn Pharma Inc.
  • Bellerophon Therapeutics Inc.
  • Endeavor Biomedicines Inc.
  • Horizon Therapeutics Public Limited Company
  • Pliant Therapeutics Inc.
  • Suzhou Zelgen Biopharmaceuticals Co. Ltd.
  • United Therapeutics Corp
  • Vicore Pharma Holding AB

Methodology

Loading
LOADING...

Related Topics

Related Reports

Global Idiopathic Pulmonary Fibrosis Market by Drug Type (Nintedanib, Pirfenidone), Distribution Channel (Offline, Online), End-User - Forecast 2024-2030 - Product Image

Global Idiopathic Pulmonary Fibrosis Market by Drug Type (Nintedanib, Pirfenidone), Distribution Channel (Offline, Online), End-User - Forecast 2024-2030

  • Report
  • 181 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis - Global Clinical Trials Review, 2024 - Product Image

Idiopathic Pulmonary Fibrosis - Global Clinical Trials Review, 2024

  • Clinical Trials
  • 454 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Image

Idiopathic Pulmonary Fibrosis Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • 88 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update - Product Image

Idiopathic Pulmonary Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update

  • Report
  • 430 Pages
  • Global
From
Cough in Idiopathic Pulmonary Fibrosis (IPF) - Pipeline Insight, 2024 - Product Image

Cough in Idiopathic Pulmonary Fibrosis (IPF) - Pipeline Insight, 2024

  • Drug Pipelines
  • 60 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.